Who owns GAIN THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Gain Therapeutics stock

Who bought or sold GAIN THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DME Capital Management 566k $1.0M 0% Sep 2024
 View chart
Gotham Asset Management 335k $7.4M 100% Sep 2024
 View chart
Geode Capital Management 272k $484k 48% Sep 2024
 View chart
Vanguard Group 145k $186k 22% Jun 2024
 View chart
Cable Car Capital 145k $186k 100% Jun 2024
 View chart
BlackRock 85k $151k 100% Sep 2024
 View chart
BlackRock 85k $108k 12% Jun 2024
 View chart
Jones Financial Companies, L.L 54k $107k 100% Sep 2024
 View chart
Renaissance Technologies 53k $95k -55% Sep 2024
 View chart
Northern Trust 45k $80k -3% Sep 2024
 View chart
Bridgeway Capital Management 40k $51k 33% Jun 2024
 View chart
State Street Corporation 34k $44k 12% Jun 2024
 View chart
Susquehanna International 10k $18k 100% Sep 2024
 View chart
Simplex Trading 4.8k $8.0k -47% Sep 2024
 View chart
Creekmur Asset Management 4.4k $7.9k 0% Sep 2024
 View chart
Bank of America Corporation 3.6k $6.4k 2% Sep 2024
 View chart
Morgan Stanley 3.3k $4.2k 18% Jun 2024
 View chart
Wells Fargo & Company 2.7k $4.7k 0% Sep 2024
 View chart
Tower Research Capital 1.7k $2.2k -63% Jun 2024
 View chart
Group One Trading 1.4k $2.5k -81% Sep 2024
 View chart

Who sold out of Gain Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Alyeska Investment Group Jun 2024 450k $576k
Hohimer Wealth Management Jun 2024 330k $422k
CM Management Jun 2024 90k $115k
Warberg Asset Management Jun 2024 52k $66k
Virtu Financial Jun 2024 27k $35k
Millennium Management Jun 2024 23k $30k
Gilbert & Cook Jun 2024 10k $13k